1. Олисова О.Ю. Совершенствование диагностики и лечения доброкачественной лимфоплазии кожи / О.Ю. Олисова, Е.М. Анпилогова, Х.С. Косумова, Е.Е. Никулина // Российский журнал кожных и венерических болезней. 2021. Т. 24. № 5. С. 429–442. https://doi.org/10.17816/dv96711
2. Самцов А.В. Клинические, гистологические и иммуногистохимические особенности лимфом кожи на современном этапе / А.В. Самцов, И.Э. Белоусова // Вестник дерматологии и венерологии. 2006. № 1. С. 3–6.
3. Allison R. Photodynamic Therapy (PDT): PDT Mechanisms / R. Allison, K. Moghissi // Clin Endosc. 2013. Vol. 46. P. 24–29. doi: 10.5946/ce.2013.46.1.24.
4. Bouchy C. Hyperplasie lymphoïde chronique (pseudolymphome) sur l'encre rouge de tatouage [Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo] / C. Gardair Bouchy, R. Kerdraon, N. Kluger, P. Armingaud, A. Wakosa, E. Estève // Ann Pathol. 2013. Vol. 33. N. 4. P. 273–277. French. doi: 10.1016/j.annpat.2013.04.005.
5. Bouloc A. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas / A. Bouloc, M. Delfau-Larue, B. Lenormand, F. Meunier, J. Wechsler, et al. // Arch Dermatol. 1999. Vol. 135. N. 2. P. 168–172. doi: 10.1001/archderm.135.2.168.
6. Bowman E. Developmental switches in chemokine response profiles during B-cell differentiation and maturation / E. Bowman, J. Campbell, D. Soler et al. // J. Exp. Med. 2000. Vol. 191. P. 1303–1318.
7. Brouwer E. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener’s granulomatosis and clinically related disorders / E. Brouwer, J. Tervaert, G. Horst, M. Huitema, M. van der Giessen, P. Limburg, C. Kallenberg // Clin Exp Immunol. 1991. Vol. 83. N. 3. P. 379–386.
8. Burg G. Cutaneous pseudolymphomas. In: Burg G, Kempf W, editors. Cutaneous lymphomas / G. Burg, W. Kempf, D. Kazakov. London, UK: Taylor & Francis; 2005.
9. Burg G. Cutaneous lymphomas, pseudolymphomas, and related disorders / G. Burg, O. Braun-Falco. Berlin: Springer Verlag, 1983.
10. Cadera E. NF-kappaB activity marks cells engaged in receptor editing / E. Cadera, F. Wan, R. Amin, H. Nolla, M. Lenardo, M. Schlissel // J. Exp. Med. 2009. Vol. 206. P. 1803–1816.
11. Cassisa A. Primary Cutaneous Follicle Center Lymphoma Clear Cell Variant: Expanding the Spectrum of Cutaneous Clear Cell Neoplasms / A. Cassisa, F. Colpan, R. Rinaldi, L. Cima // Am J. Dermatopathol. 2018. Vol. 40. N. 11. P. 849–853. doi: 10.1097/DAD.0000000000001195.
12. Cerroni L. Diagnostic immunohistology: cutaneous lymphomas and pseudolymphomas / L. Cerroni, H. Kerl // Semin Cutan Med Surg. 1999. Vol. 8. N. 1. P. 64–70. doi: 10.1016/s1085-5629(99)80010-8.
13. Cesinaro A. Granuloma faciale: a cutaneous lesion sharing features with IgG4-associated sclerosing diseases / A. Cesinaro, S. Lonardi, F. Facchetti // Am J. Surg Pathol. 2013. Vol. 37. P. 66–73.
14. Charli-Joseph Y. Approach to Cutaneous Lymphoid Infiltrates: When to Consider Lymphoma? / Y. Charli-Joseph, M. Gatica-Torres, L. Pincus // Indian J. Dermatol. 2016. Vol. 61. N. 4. P. 351–374. doi: 10.4103/0019-5154.185698.
15. Choi E. Corticosteroid phobia: a questionnaire study using TOPICOP score / E. Choi, N. Chandran, C. Tan // Singapore Med J. 2020. Vol. 61. N. 3. P. 149–153. doi: 10.11622/smedj.2019110.
16. Choi M. Clinical and histopathological characteristics of cutaneous lymphoid hyperplasia: a comparative study according to causative factors / M. Choi, K. Lee, D. Lim, C. Won, S. Chang, M. Lee, et al. // J. Clin Med. 2020. Vol. 9. N. 4. P. 1217. doi: 10.3390/jcm9041217.
17. Choi M. A case of cutaneous lymphoid hyperplasia after hyaluronic acid filler injection and fat grafting / M. Choi, C. Won, S. Chang, M. Lee, J. Choi, W. Lee // Australas J Dermatol. 2019. Vol. 60. N. 1. e71–73. doi: 10.1111/ajd.12907.
18. Comfere N. Views of dermatopathologists about clonality assays in the diagnosis of cutaneous T-cell and B-cell lymphoproliferative disorders / N. Comfere, U. Sundram, M. Hurley, B. Swick // J Cutan Pathol. 2018. Vol. 45. N. 1. P. 39–47. doi: 10.1111/cup.13072.
19. Dadban, A. Cutaneous lymphoid hyperplasia on a preexistent melanocytic nevus / A. Dadban, F. Truchetet // Dermatology. 2008. Vol. 217. N. 3. P. 199–200. doi: 10.1159/000141650.
20. Dionyssopoulos A. T- and B-cutaneous pseudolymphomas treated by surgical excision and immediate reconstruction / A. Dionyssopoulos, I. Mandekou-Lefaki, F. Delli, D. Kourtis, A. Nikolis, et al. // Dermatol Surg. 2006. Vol. 32. P. 1526–1529.
21. Dodiuk-Gad R. Systemic glucocorticoids: important issues and practical guidelines for the dermatologist / R. Dodiuk-Gad, S. Ish-Shalom, S. Shear // Int J. Dermatol. 2015. Vol. 54. N. 6. P. 723–729. doi: 10.1111/ijd.12642.
22. Ebrahim A. Hematologic malignancies: newer strategies to counter the BCL-2 protein / A. Ebrahim, H. Sabbagh, A. Liddane, A. Raufi, M. Kandouz, A. Al-Katib // J Cancer Res Clin Oncol. 2016. Vol. 142. N. 9. P. 2013–2022. doi: 10.1007/s00432-016-2144-1.
23. Egawa G. Role of Lymphoid Structure in Skin Immunity / G. Egawa, K. Kabashima // Curr Top Microbiol Immunol. 2020. Vol. 426. P. 65–82. doi: 10.1007/82_2020_206.
24. Fan L. Photodynamic therapy for rosacea in Chinese patients / L. Fan, R. Yin, T. Lan, M. Hamblin // Photodiagnosis Photodyn Ther. 2018. Vol. 24. P. 82–87. doi: 10.1016/j.pdpdt.2018.08.005.
25. Fernandez-Flores A. The role of IgG4 in cutaneous pathology / A. Fernandez-Flores // Rom J Morphol Embryol. 2012. Vol. 53. N. 2. P. 221–231.
26. Fernandez-Faith E. Cutaneous sarcoidosis: differential diagnosis / E. Fernandez-Faith, J. McDonnell // Clin Dermatol. 2007. Vol. 25. N. 3. P. 276–287. doi: 10.1016/j.clindermatol.2007.03.004.
27. Gilliam A. Cutaneous lymphoid hyperplasias / A. Gilliam, G. Wood // Semin Cutan Med Surg. 2000. Vol. 19. N. 2. P. 133–141. doi: 10.1016/s1085-5629(00)80011-5.